Clinical Observation on Ceftriaxone Combined with Ranitidine in Treatment of Acute Pancreatitis
10.13241/j.cnki.pmb.2017.23.038
- VernacularTitle:头孢曲松联合雷尼替丁治疗急性胰腺炎患者的临床研究
- Author:
Zhuo CHENG
;
Ligong DENG
;
Li ZHANG
;
Fan YANG
;
Rong ZHU
- Keywords:
Acute pancreatitis;
Ceftriaxone;
Ranitidine;
Interleukin-6;
C-reactive protein;
Clinical curative effect
- From:
Progress in Modern Biomedicine
2017;17(23):4560-4563
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical effect and mechanisms of ceftriaxone combined with ranitidine on the acute pancreatitis.Methods:92 cases of patients with acute pancreatitis were selected and randomly divided into the control group (n=46) and experimental group (n=46),the control group was treated with ceftriaxone,and the experimental group was treated with ranitidine based on the control group,the serum levels of intedeukin-6 (IL-6),c-reactive protein(CRP),platelet activating factor (PAF),superoxide dismutase (SOD),propylene glycol (MDA),gastric secrete element,stomach,heart rate (HR),mean arterial pressure (MAP),and the relief time of clinical manifestation and the clinical efficacy were observed and compared between the two groups.Results:After treatment,the serum levels ofIL-6,CRP,PAF,MDA,gastric secrete element and HR of experimental group were significantly lower than those of the control group (P＜0.05).The serum levels of SOD,stomach motion element and MAP of experimental group were higher than those of the control group (P＜0.05).The relief time of clinical manifestation and total efficiency of experimental group were better than those of the control group (P＜0.05).Conclusions:Ceftriaxone combined with ranitidine could effectively enhance the clinical efficacy of acute pancreatitis,which might be related to the anti-oxidation and anti-inflammation.
